Conventional glutathione, regardless of dose, cannot consistently reach that threshold via oral administration or unprotected topical application
For TB-500, which was evaluated primarily for wound healing, FDA reviewers and several Committee members raised concerns about its potential relationship to tumor progression, although FDA acknowledged that no studies had been conducted on TB-500 itself
FDA: July 23-24, 2026 Pharmacy Compounding Advisory Committee Meeting Provides the official agenda, substances and uses evaluated, meeting materials, and archived broadcasts
Weight loss and better blood sugar control can contribute to improved cardiovascular outcomes
The plaintiff demands a judgment against the defendants for pain and suffering, severe and permanent personal injury, healthcare costs, and medical monitoring